Derrick Neba Nebangwa

5PUBLICATIONS
14CO-AUTHORS
Molecular targetsMajor global burdens of diseaseMedical infection agents (incl. prions)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 01, 2026
Safety and immunogenicity of an adjuvanted human onchocerciasis vaccine candidate, OvMANE1: preclinical evaluation in a mice model.

|Feb 26, 2025
One Health Approach to the Computational Design of a Lipoprotein-Based Multi-Epitope Vaccine Against Human and Livestock Tuberculosis.

Robert Adamu Shey, Gordon Takop Nchanji, Tangan Yanick Aqua Stong

|Oct 21, 2024
Predictive immunoinformatics reveal promising safety and anti-onchocerciasis protective immune response profiles to vaccine candidates (Ov-RAL-2 and Ov-103) in anticipation of phase I clinical trials.

Derrick Neba Nebangwa, Robert Adamu Shey, Daniel Madulu Shadrack

|Jul 01, 2020
Virtual Screening Identifies Chebulagic Acid as an Inhibitor of the M2(S31N) Viral Ion Channel and Influenza A Virus.

Maggie C Duncan, Pascal Amoa Onguéné, Ibuki Kihara

|Jun 26, 2020
In Silico Design and Validation of OvMANE1, a Chimeric Antigen for Human Onchocerciasis Diagnosis.

Cabirou Mounchili Shintouo, Robert Adamu Shey, Derrick Neba Nebangwa

Pageof 1

Frequent Collaborators

3 joint publications

Stephen Mbigha Ghogomu

3 joint publications

Robert Adamu Shey

2 joint publications

Fidele Ntie-Kang

2 joint publications

Cabirou Mounchili Shintouo